Test Code |
Test Name |
Location |
Methodology |
Disease Category |
MRP |
Days |
MGM583
|
Fabry disease (GLA) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Metabolic Disorders |
17000 |
16 |
MGM584
|
Achondroplasia (FGFR3) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Skeletal dysplasia |
17000 |
16 |
MGM599
|
Androgen receptor (AR) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Endocrinology |
17000 |
16 |
MGM604
|
Mondini defect (SLC26A4) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
ENT |
17000 |
16 |
MGM611
|
Factor VII deficiency (F7) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Hematology |
17000 |
16 |
MGM617
|
Von Willebrand disease (VWF) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Hematology |
17000 |
16 |
MGM618
|
Agammaglobulinemia (BTK) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Immunology |
17000 |
16 |
MGM619
|
Chediak-Higashi syndrome (LYST) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Immunology |
17000 |
16 |
MGM621
|
Cystic fibrosis (CFTR) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Rare inherited diseases |
17000 |
16 |
MGM626
|
Fanconi bickel syndrome (SLC2A2) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Metabolic Disorders |
17000 |
16 |
MGM628
|
GLUT1 deficiency (SLC2A1) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Metabolic Disorders |
17000 |
16 |
MGM634
|
Hypercholesterolemia gene panel[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Endocrinology |
17000 |
16 |
MGM635
|
Hyperargininemia (ARG1) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Metabolic Disorders |
17000 |
16 |
MGM638
|
McArdle disease (PYGM) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Metabolic Disorders |
17000 |
16 |
MGM639
|
Menkes disease (ATP7A) gene analysis[Expedited TAT] |
Bangalore |
Next Generation Sequencing |
Metabolic Disorders |
17000 |
16 |
|
|